ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...

Overall, recent studies have shown that GLP-1 drugs have led to a 10-20% reduction in body weight and lowered the risk of heart attack, stroke and cardiovascular death by approximately 20%.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...

The world's biggest food company is targeting Ozempic users with small, protein-packed meals for under $5.

“It is not one-size-fits-all, and every medication can have risks and side effects,” Mao added in a university news release. ...

Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...

Meanwhile, Lilly’s 2023 revenue exceeded $34 billion, growing 20% year-over-year. Its tirzepatide brands Mounjaro and ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

The demand for medications like Ozempic continues to cause shortages for both those seeking weight loss and patients with ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 597.82% and ...

Eli Lilly and Company’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...